A nationally representative study that was recently conducted reports that about 29% of participants who had a suicide attempt history had achieved a state of complete mental health.
In order to make that determination, participants had to report high levels of psychological and social well-being in the last month, almost daily life satisfaction or happiness in the last month, and freedom from suicidality and mental ailments such as substance dependence and psychiatric disorders to be considered in complete mental health.
The study was published in the “Archives of Suicide Research.”
Prof. Esme Fuller-Thomson from the University of Toronto, the study’s lead author, stated that this was a hopeful discovery for people struggling with suicidal ideation. Fuller-Thomson, who is also the director of the Institute for Life Course and Aging, explained that the group’s discovery showed that a good number of people who had a history of suicide attempts went on to achieve high levels of psychological flourishing and happiness.
For their study, the scientists assessed a sample of more than 750 Canadians who had tried to commit suicide at a point in their lives. The researchers recruited the participants using data obtained from the Canadian Community Health Survey-Mental Health at Statistics Canada.
Assistant Prof. Philip Baiden, who was the study’s co-author, stated that the researchers discovered social support to be a primary factor in supporting the well-being of people with a history of suicide attempts. Baiden, who hails from the University of Texas at Arlington, added that the respondents who had an individual to confide in were more likely to be in complete mental health. Other factors that were linked to complete mental health included absence of insomnia and being free from chronic pain.
Ian Mahoney, another co-author, stated that the study also highlighted factors that acted as barriers to positive mental health outcomes after an individual had attempted to commit suicide. He noted that it was crucial to address modifiable factors, including chronic pain and insomnia, in order to support this population’s well-being.
The study also found that complete mental health was more prevalent among individuals with higher income and individuals who were older; women were also more prone to be categorized in complete mental health.
Another co-author of the study Andie MacNeil asserted that while remission from suicidal ideation was an essential factor in the recovery process, the study drew attention to the different mental health outcomes. He noted that the research also incorporated measures of psychological and social well-being that encouraged the use of a more holistic approach to an individual’s recovery from suicidality.
In case the suicidal ideation was the result of an underlying psychiatric condition, there is even more hope for the patients because several companies, including Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), are working to develop a new class of psychiatry medicines whose efficacy is likely to be greater than that of the existing medications, and that means one would have the causes of their condition addressed instead of only managing the symptoms.
NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
